Research Article
Discovery and Validation of Serum MicroRNAs as Early Diagnostic Biomarkers for Prostate Cancer in Chinese Population
Table 2
Expression profiles of candidate microRNAs on qRT-PCR in serum samples.
| microRNA | PCa VS. BPH | PCa VS. Nor | BPH VS. Nor |
| miR-365a-3p | 0.0239 | 0.0963 | 0.8812 | miR-4286 | 0.0222 | 0.8545 | 0.0092 | miR-590-5p | 0.3248 | 0.9437 | 0.5679 | miR-342-3p | 0.6984 | 0.5684 | 0.5878 | miR-361-5p | 0.2538 | 0.3792 | 0.7727 | miR-424-5p | <0.001 | 0.4443 | 0.0031 | let-7d-5p | 0.5951 | 0.4938 | 0.1978 | let-7c-5p | 0.0913 | 0.0509 | 0.7437 | let-7g-5p | 0.938 | 0.4856 | 0.4285 | miR-26b-5p | 0.9556 | 0.5166 | 0.4967 | miR-29b-3p | 0.0901 | 0.5166 | 0.4967 | miR-877-3p | 0.1274 | 0.1137 | 0.035 | miR-27a-3p | 0.1584 | 0.0716 | 0.3286 |
|
|
PCa: prostate cancer; BPH: benign prostate hyperplasia; Nor: normal; VS.: versus.
|